Johnson Investment Counsel’s Dr. Reddy's Laboratories RDY Stock Holding History

Johnson Investment Counsel’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,660	Closed	-$311K	–	867
2025 Q2	$311K	Hold	20,660	–	–	﹤0.01%	661
2025 Q1	$273K	Sell	20,660 -4,100	-17%	-$56.6K	﹤0.01%	670
2024 Q4	$391K	Hold	24,760	–	–	﹤0.01%	580
2024 Q3	$393K	Hold	24,760	–	–	﹤0.01%	562
2024 Q2	$377K	Hold	24,760	–	–	﹤0.01%	546
2024 Q1	$363K	Buy	24,760 +5,800	+31%	+$84.7K	﹤0.01%	565
2023 Q4	$264K	Hold	18,960	–	–	﹤0.01%	613
2023 Q3	$254K	Hold	18,960	–	–	﹤0.01%	588
2023 Q2	$239K	Hold	18,960	–	–	﹤0.01%	598
2023 Q1	$216K	Buy	+18,960	New	+$205K	﹤0.01%	611
2022 Q3	–	Sell	-18,960	Closed	-$210K	–	660
2022 Q2	$210K	Hold	18,960	–	–	﹤0.01%	609
2022 Q1	$211K	Hold	18,960	–	–	﹤0.01%	630
2021 Q4	$248K	Hold	18,960	–	–	﹤0.01%	596
2021 Q3	$247K	Hold	18,960	–	–	﹤0.01%	578
2021 Q2	$279K	Hold	18,960	–	–	﹤0.01%	551
2021 Q1	$233K	Hold	18,960	–	–	﹤0.01%	558
2020 Q4	$270K	Hold	18,960	–	–	﹤0.01%	510
2020 Q3	$264K	Hold	18,960	–	–	﹤0.01%	501
2020 Q2	$201K	Buy	+18,960	New	+$193K	﹤0.01%	551
2016 Q3	–	Sell	-20,950	Closed	-$214K	–	583
2016 Q2	$214K	Buy	+20,950	New	+$192K	0.01%	509
2015 Q4	–	Sell	-20,950	Closed	-$267K	–	558
2015 Q3	$267K	Hold	20,950	–	–	0.01%	459
2015 Q2	$231K	Buy	+20,950	New	+$231K	0.01%	492

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Johnson Investment Counsel's RDY Position: Q3 2025 in Review

Johnson Investment Counsel sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 20,660 shares — an estimated $311K sold.

Johnson Investment Counsel first reported a position in RDY in Q2 2015 and held it in 22 quarters. The position peaked at $393K in Q3 2024. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

Johnson Investment Counsel reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
Johnson Investment Counsel sold 20,660 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $311K.
Johnson Investment Counsel first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 22 quarters.
Johnson Investment Counsel's Dr. Reddy's Laboratories position peaked at $393K in Q3 2024.
228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Johnson Investment Counsel's 13F filing for Q3 2025, filed 6 Nov 2025.